Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

October 31, 2009

Conditions

Hereditary AngioedemaAngioneurotic EdemaGenetic Disorders

Interventions

DRUG

recombinant human C1 inhibitor

DRUG

Placebo

Trial Locations (2)

Emergency County Hospital, Internal Medicin Clinica, Allergology-Immunology Department, Târgu Mureş

For information on sites, please contact Pharming Medical Affairs Deparment, Leiden